This article was originally published in The Tan Sheet
Vitamin and herb marketer's 4Q sales rose 4% to $76.6 mil., driven by a 25% increase in international business, firm reports Feb. 6. Domestic revenue declined 9% in the quarter to $41.3 mil. due to market softness. Year-end 2000 sales totaled $314.8 mil., up 7%, with international revenue accounting for 44% of sales. Firm also announces new, board-authorized, 1 mil.-common share repurchase program to replace previous program that was completed in January
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC